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CASE REPORT
Anatomically, the spleen is made up of two parts,
the white pulp and red pulp. The white pulp is
made up of lymphocytes, and the red pulp of a
complex network of venous sinuses and the cords
of Billroth. The sinuses are lined by specific en-
dothelial cells, presenting with both endothelial
and histiocytic markers, also known as littoral cells.
The cord comprises splenic macrophages. Because
the vascular structure of the spleen is complex
and distinct from the vessels of other organs, there
are some vascular neoplasms that are unique to
the spleen such as littoral cell hemangioma,
splenic hamartoma, etc. Recently, a novel splenic
vascular tumor was described by Rosai1 and Martel
et al.2 Grossly, the tumor usually presents as a
multinodular, well-circumscribed mass containing
a hypervascular core. Therefore, it has been desig-
nated as sclerosing angiomatoid nodular trans-
formation (SANT). Although the tumor was
identified only 3 years ago, about 50 probable
cases have been reported in the literature.1–8
Patients with SANT have a relatively high preva-
lence (20%) of concurrent diseases at other sites,
and most are cases of malignancy such as leukemia,
lung cancer, colonic carcinoma, gastric carcinoma,
and renal cell carcinoma etc.2 Herein, we report a
patient with SANT and multiple calcifying fibrous
pseudotumors (CFPTs) of the mesentery. No such
combination of these two unusual tumors have
previously been reported. We performed exten-
sive immunohistochemical staining and reviewed
the clinicopathologic characteristics of these two
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tumors to determine the possible association 
between them.
Case Report
A 43-year-old woman, a hepatitis B virus carrier,
was noted to have a hypoechoic splenic tumor
during a routine ultrasonography examination in
February 2004. Four months later, she began to
feel left flank pain and lost 9 kg within 6 months
thereafter. She was admitted to the National Taiwan
University Hospital for evaluation. Laboratory
examinations including complete blood count,
biochemistry test, CA-19-9, and C-reactive pro-
tein were all unremarkable, but splenomegaly was
noted on physical examination. Computed tomo-
graphy (CT) showed two lobulated low-density
masses in the spleen (Figure 1). Magnetic reso-
nance imaging (MRI) revealed that the tumors
were of low signal on T2-weighted images and of
mild low signal on T1-weighted images, without
definite enhancement. Thrombosed hemangioma,
lymphoma, or chronic abscess was suspected. The
patient received total splenectomy in January
2005. On operation, some small white nodules
were also found over the gastric wall and omen-
tum, and they were removed completely. No re-
currence was noted during postoperative follow-up.
Grossly, the spleen weighed 180g. Upon cut-
ting, two well-circumscribed round tumors were
found in the spleen, measuring 3.5 × 3.5 × 3.0 cm
and 3.0 × 2.0 × 2.0 cm in size, respectively. The
tumors comprised some hemorrhagic nodules,
which were separated by thick fibrotic septa
(Figure 2). Four mesenteric tumors were also
submitted, and they were white and elastically
firm, measuring up to 1.4 cm in diameter. Micro-
scopically, the splenic tumors comprised multi-
ple nodules arranged in a lobular pattern. These
nodules had a central vascular core and were sur-
rounded by a fibroedematous cortical zone and
an outermost fibrotic shell (Figure 3). On high
power examination, three types of vascular struc-
ture were found in the tumor. First, capillary-like
vessels, which were the most frequent vascular
component and mainly located within the vascu-
lar core. Histologically, they were characterized
by the presence of erythrocytes within the lu-
mina. Second, the larger vessels, which had open
and empty lumina and resembled the sinusoids
in the red pulp. Third, ectatic veins, which usu-
ally had a well-defined vascular wall. Immuno-
histochemically, different vessels in the tumor
had distinct immunophenotypes (Figure 4). The
capillaries and ectatic veins were reactive to CD31
and CD34 but negative for CD8. The sinusoid-
like vessels were positive for CD31 and CD8, but
negative for CD34. The spindle-shaped cells of
the tumor were negative for desmin, CD1a, S-100,
CD21, and anaplastic lymphoma kinase (ALK)-1.
Figure 1. Post-contrast abdominal computed tomography
shows two tumors in the spleen (arrows). Figure 2. The splenic tumors (arrows) are well-circumscribed
and contain red–brown angiomatoid nodules in a lobular
pattern separated by gray–white septa.
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Figure 3. (A) In whole-mount view, the splenic tumor is composed of multiple nodules of various sizes. *Normal splenic
tissue. The dotted square region is magnified in (B). (B) The center (zone 1) of the nodule has an angiomatoid appearance.
The cortex (zone 2) is composed of fibroedematous tissue and ectatic vessels. The fibrous septum (zone 3) consists of
collagen bundles. (Hematoxylin & eosin, 20×.)
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Figure 4. Immunostaining shows that all the vessels in sclerosing angiomatoid nodular transformation: (A) are positive
for CD31; (B) the cord capillaries (short arrows) are positive for CD34; and (C) the dilated sinusoid vessels (long arrows)
are positive for CD8.
In addition, in situ hybridization for Epstein Barr
Virus (EBV)-encoded small RNA (EBER) was also
negative.
The separated mesenteric nodules were fibrotic
and well circumscribed (Figure 5A). Microscop-
ically, they were composed of thick hyalinized
collagen bundles arranged in whorls or haphaz-
ard patterns admixed with scanty bland-looking
spindle cells. Occasional psammoma bodies 
and dystrophic calcifications were present in
these nodules. Focal lymphocytic infiltration
with lymphoid follicle formation was also noted
(Figure 5B). Immunohistochemically, the spin-
dle cells were reactive to factor XIIIa (Figure 6)
and vimentin, but negative for CD34, CD68,
desmin, S-100 protein, epithelial membrane
antigen (EMA), muscle-specific actin, calretinin,
ALK, CD117, and bcl-2. In situ hybridization for
EBER was also negative. The microscopic features
and immunohistochemical characteristics of the
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mesenteric nodules were consistent with the di-
agnosis of CFPT.
Discussion
Vascular tumors are the most common neoplasms
of the spleen, and they include several different
entities, some of which are unique to that organ.
SANT is a novel vascular lesion of the spleen, 
and it must be differentiated from other vascular
tumors or tumor-like lesions of the spleen, in-
cluding hamartoma, littoral cell angioma (LCA),
inflammatory pseudotumor, and follicular den-
dritic cell tumor (FDC).
Hamartoma is a tumor composed of a disor-
ganized overgrowth of mature cells and tissues that
are normally present within the organ. Splenic
hamartoma is an overgrowth of sinus-like struc-
tures of the red pulp, which is immunoreactive
to CD8. In contrast, SANT contains three types of
vessels, i.e. capillaries, sinusoids, and small veins.
Each vascular type has a distinct phenotype and
recapitulates the normal vascular structure of
splenic red pulp. The capillaries of SANT are usu-
ally CD31+, CD34+, and CD8–, resembling the
capillaries in the cord of normal splenic red pulp.
The sinusoids are CD31+, CD34–, and CD8+,
reminiscent of the sinusoids in the normal red
pulp. The small veins are also CD34+, CD31+, and
CD8–. Therefore, SANT can be regarded as a vari-
ant of splenic hamartoma5,8 with an overgrowth
of all three types of vessels in the red pulp.
LCA is a unique vascular neoplasm of the
spleen. Grossly, it usually presents as a nodular
lesion with sponge-like vascular spaces. Micro-
scopically, LCA comprises anastomosing sinusoidal
vascular channels lined by tall endothelial cells.
Immunohistochemically, these tall endothelial
cells usually express both endothelial (factor VIII,
A B
Figure 5. (A) Whole-mount view shows that the calcifying fibrous pseudotumor (arrows) is well-circumscribed and 
fibrotic. (B) The tumor is composed of thick collagen fibers arranged in whorls or haphazardly. Scattered psammoma
bodies (arrow) and lymphocytic infiltration can be seen. (Hematoxylin & eosin, 40×.)
Figure 6. Immunostain for factor XIIIa. The spindle cells in
the calcifying fibrous pseudotumor are diffusely positive.
CD31, and CD34) and histiocytic markers (CD68,
KP-1) but are negative for CD8. Therefore, it is easy
to differentiate LCA from SANT by gross, micro-
scopic, and immunohistochemical examinations.
Inflammatory pseudotumor is a myofibro-
blastic proliferative lesion with an edematous
myxoid background rich in blood vessels and 
inflammatory cells. Because of the angiomatoid
or “granulation tissue-like” core and a fibromyx-
oid cortex, SANT has been thought to be a vari-
ant of inflammatory pseudotumor.2 Unlike the
conventional inflammatory pseudotumor, SANT
has fewer inflammatory cells and myofibroblasts.
In addition, the EBV genome is usually present
in the tumor cells of splenic inflammatory pseudo-
tumor but not in SANT. Therefore, there are still
certain distinct histologic and immunohistochemi-
cal differences between SANT and inflammatory
pseudotumor.
In addition, SANT has to be differentiated from
FDC, which can also be found in the spleen occa-
sionally. FDC is characterized by a proliferation of
oval to spindle cells that form fascicles and whorls.
Immunohistochemically, the spindle cells of FDC
usually express CD21, S-100 protein, and CD35.
Thus, FDC can be differentiated from SANT by
immunohistochemical staining. Although cav-
ernous hemangioma is the most common vascular
neoplasm of the spleen, it is not difficult to differ-
entiate splenic hemangioma from SANT by gross
and microscopic examinations.
Because SANT is a recently described entity
and only a limited number of cases have been 
reported, the pathogenesis of SANT is unknown.
Whether it is a neoplasm or a reactive lesion is still
unclear. Several hypotheses have been proposed
for the formation of SANT.2,5,8 First, the angioma-
toid nodule of SANT is similar to an organized
hematoma. SANT may thus have evolved from a
hematoma. Second, since the angiomatoid nod-
ules of SANT comprise red pulp elements only,
SANT may be considered a variant of splenic
hamartoma that has undergone a peculiar form
of sclerosis. Third, the internodular zones of SANT
are often indistinguishable from inflammatory
pseudotumor. Therefore, SANT may be a peculiar
variant of inflammatory pseudotumor. Finally, in
some patients with space-occupying lesions in the
spleen, nodular transformation of the red pulp can
be found. Therefore, the angiomatoid nodules of
SANT may also represent a peculiar transformation
of the red pulp in response to an exaggerated
stromal proliferation.2,9 The above observations
suggest that SANT is more like a reactive lesion
rather than a true neoplasm. We also agree with
this hypothesis because patients with SANT have
a relatively high prevalence (20%) of concurrent
diseases at other sites; our patient also had multiple
CFPTs on the mesentery.
CFPT is an uncommon tumor-like lesion first
described by Rosenthal and Abdul-Karim10 in
1988. In 1993, Fetsch et al11 added 10 additional
cases and proposed the designation “calcifying
fibrous pseudotumor”. The tumor usually arises
from the peritoneal subserosa or the soft tissue.
Lesions of the soft tissue tend to occur in child-
hood, while lesions of the peritoneum can be
found in both children and older patients. This
implies that the two groups of CFPT may have
different mechanisms of tumorigenesis.
Grossly, CFPT usually presents as a well-
circumscribed gray–white elastic tumor. On the
serosal surface, it may grow as a pedunculated
tumor. Its size is variable, ranging from less than
1 cm to more than 10 cm. Lesions in the soft tissue
tend to be larger than those in the peritoneum.
Microscopically, CFPTs are characterized by
four components: (1) dense hyalinized collagen
bundles; (2) bland spindle-shaped fibroblasts;
(3) lymphoplasmacytic infiltrations; and (4)
psammomatous or dystrophic calcifications. The
collagen bundles are often arranged haphazardly
or in whorls. The lymphoid infiltration may ag-
gregate as lymphoid follicles or germinal centers.
Immunohistochemically, the spindle-shaped fi-
broblastic cells in CFPT are usually positive for
vimentin and factor XIIIa. They are also variable
for smooth muscle actin and CD68 but negative
for cytokeratin, desmin, S-100, EMA, calretinin,
ALK, CD117, and bcl-2.
The etiology of CFPT is still unknown. Some
researchers suggest that CFPT might arise from
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an inflammatory myofibroblastic tumor (IMT),
since both lesions coexist in some patients, and
transformation between IMT and CFPT has also
been reported.12,13 However, there are still some
differences between the two tumors. First, calcifi-
cation is a common feature of CFPT but rare in
IMT. Second, up to 60% of IMTs express immu-
noreactivity for ALK-1,14,15 which is rare in CFPT.
Third, EBV infection is frequently detected in intra-
abdominal IMTs but never described in CFPT.
Therefore, the relationship between IMT and CFPT
remains controversial, although there might be a
small subgroup of IMT that evolves to CFPT.
Clinically, both SANT and CFPT are benign
lesions and generally do not cause mortality. Most
of them were found incidentally or presented as
palpable masses. Peritonitis was reported in some
patients with abdominal CFPTs, and in rare cases
symptoms related to superior vena cava and tra-
chea compression have also been described. No
recurrence of SANT following splenectomy has
been reported, but recurrence of CFPT was reported
in eight patients and three of them had multiple
lesions. Accordingly, the present case is at higher
risk of CFPT recurrence.
In summary, we reported a unique case with
coexistence of CFPT and SANT. Both lesions are
closely associated with IMT/inflammatory pseudo-
tumor. The coexistence of the two rare entities in
our patient may not be just a coincidence, and a
common reactive mechanism contributory to both
lesions is more likely.
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